Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Sexually Transmitted Diseases

  Free Subscription


Articles published in Gynecol Oncol

Retrieve available abstracts of 34 articles:
HTML format



Single Articles


    November 2021
  1. ARYASOMAYAJULA C, Chanana A, Tandel M, Kwan L, et al
    The role of high-risk HPV testing in cervical cancer surveillance.
    Gynecol Oncol. 2021 Nov 23. pii: S0090-8258(21)01606.
    PubMed     Abstract available


    July 2021
  2. CUZICK J, Du R, Adcock R, Kinney W, et al
    Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States.
    Gynecol Oncol. 2021 Jul 9. pii: S0090-8258(21)00525.
    PubMed     Abstract available


  3. SALVADO A, Miralpeix E, Sole-Sedeno JM, Kanjou N, et al
    Predictor factors for conservative management of cervical intraepithelial neoplasia grade 2: Cytology and HPV genotyping.
    Gynecol Oncol. 2021 Jul 2. pii: S0090-8258(21)00515.
    PubMed     Abstract available


    June 2021
  4. CHATZISTAMATIOU K, Tsertanidou A, Moysiadis T, Mouchtaropoulou E, et al
    Comparison of different strategies for the triage to colposcopy of women tested high-risk HPV positive on self-collected cervicovaginal samples.
    Gynecol Oncol. 2021 Jun 28. pii: S0090-8258(21)00516.
    PubMed     Abstract available


  5. VAN KEER S, Peeters E, Vanden Broeck D, De Sutter P, et al
    Clinical and analytical evaluation of the RealTime High Risk HPV assay in Colli-Pee collected first-void urine using the VALHUDES protocol.
    Gynecol Oncol. 2021 Jun 22. pii: S0090-8258(21)00490.
    PubMed     Abstract available


    May 2021
  6. SONG F, Belinson JL, Yan P, Huang X, et al
    Evaluation of p16(INK4a) immunocytology and human papillomavirus (HPV) genotyping triage after primary HPV cervical cancer screening on self-samples in China.
    Gynecol Oncol. 2021 May 28. pii: S0090-8258(21)00410.
    PubMed     Abstract available


    March 2021
  7. GIANNELLA L, Giorgi Rossi P, Delli Carpini G, Di Giuseppe J, et al
    Age-related distribution of uncommon HPV genotypes in cervical intraepithelial neoplasia grade 3.
    Gynecol Oncol. 2021 Mar 29. pii: S0090-8258(21)00263.
    PubMed     Abstract available


  8. CHANG CL, Ho SC, Su YF, Juan YC, et al
    DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.
    Gynecol Oncol. 2021 Mar 20. pii: S0090-8258(21)00148.
    PubMed     Abstract available


  9. TEOH D, Hill EK, Goldsberry W, Levine L, et al
    Overcoming the barriers to HPV vaccination in high-risk populations in the U.S.
    Gynecol Oncol. 2021 Mar 8. pii: S0090-8258(21)00083.
    PubMed    


    January 2021
  10. BOGANI G, Sopracordevole F, Di Donato V, Ciavattini A, et al
    High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes.
    Gynecol Oncol. 2021 Jan 26. pii: S0090-8258(21)00080.
    PubMed     Abstract available


    December 2020
  11. SPINILLO A, Dominoni M, Boschi AC, Cesari S, et al
    The relationship of human papillomavirus infection with endocervical glandular involvement on cone specimens in women with cervical intraepithelial neoplasia.
    Gynecol Oncol. 2020;159:630-635.
    PubMed     Abstract available


    November 2020
  12. JANSEN EEL, Ivanus U, Jerman T, de Koning HJ, et al
    The optimal HPV-screening protocol in Eastern-Europe: The example of Slovenia.
    Gynecol Oncol. 2020 Nov 13. pii: S0090-8258(20)34058.
    PubMed     Abstract available


  13. CHODICK G, Teper GR, Levi S, Kopel H, et al
    The impact of a Facebook campaign among mothers on HPV vaccine uptake among their daughters: A randomized field study.
    Gynecol Oncol. 2020 Nov 5. pii: S0090-8258(20)34059.
    PubMed     Abstract available


    September 2020
  14. KORTEKAAS KE, Bastiaannet E, van Doorn HC, de Vos van Steenwijk PJ, et al
    Vulvar cancer subclassification by HPV and p53 status results in three clinically distinct subtypes.
    Gynecol Oncol. 2020 Sep 21. pii: S0090-8258(20)33917.
    PubMed     Abstract available


    August 2020
  15. ABEL MK, Huh WK, Chan JK
    Human papillomavirus: The other invisible enemy.
    Gynecol Oncol. 2020;158:254-255.
    PubMed    


    July 2020
  16. ARA R, Khatun S, Pervin S, Jahan M, et al
    Role of molecular biomarker human papilloma virus (HPV) E6 oncoprotein in cervical cancer screening.
    Gynecol Oncol. 2020 Jul 14. pii: S0090-8258(20)32322.
    PubMed     Abstract available


  17. HUH WK, Brady WE, Fracasso PM, Dizon DS, et al
    Phase II study of axalimogene filolisbac (ADXS-HPV) for platinum-refractory cervical carcinoma: An NRG oncology/gynecologic oncology group study.
    Gynecol Oncol. 2020 Jul 5. pii: S0090-8258(20)32317.
    PubMed     Abstract available


    April 2020
  18. GULTEKIN M, Dundar S, Keskinkilic B, Turkyilmaz M, et al
    How to triage HPV positive cases: Results of four million females.
    Gynecol Oncol. 2020 Apr 30. pii: S0090-8258(20)31008.
    PubMed     Abstract available


  19. REICH O, Regauer S, Kashofer K
    Possibly carcinogenic HPV subtypes are a cause of HSIL and negative clinical HPV tests - A European prospective single center study.
    Gynecol Oncol. 2020 Apr 27. pii: S0090-8258(20)30985.
    PubMed     Abstract available


  20. RASMUSSEN CL, Thomsen LT, Aalborg GL, Kjaer SK, et al
    Incidence of vulvar high-grade precancerous lesions and cancer in Denmark before and after introduction of HPV vaccination.
    Gynecol Oncol. 2020 Apr 7. pii: S0090-8258(20)30255.
    PubMed     Abstract available


    March 2020

  21. Editor's note to "HPV vaccines-A review of the first decade" [Gynecol. Oncol. 146 (2017) 196-204].
    Gynecol Oncol. 2020;156:750.
    PubMed    


  22. HU SY, Rezhake R, Chen F, Zhang X, et al
    Outcomes in women with biopsy-confirmed cervical intraepithelial neoplasia grade 1 or normal cervix and related cofactors: A 15-year population-based cohort study from China.
    Gynecol Oncol. 2020;156:616-623.
    PubMed     Abstract available


  23. LEE H, Choi M, Jo M, Park EY, et al
    Assessment of clinical performance of an ultrasensitive nanowire assay for detecting human papillomavirus DNA in urine.
    Gynecol Oncol. 2020;156:641-646.
    PubMed     Abstract available


    February 2020
  24. EVA LJ, Sadler L, Fong KL, Sahota S, et al
    Trends in HPV-dependent and HPV-independent vulvar cancers: The changing face of vulvar squamous cell carcinoma.
    Gynecol Oncol. 2020 Feb 6. pii: S0090-8258(20)30083.
    PubMed     Abstract available


  25. DILLEY S, Miller KM, Huh WK
    Human papillomavirus vaccination: Ongoing challenges and future directions.
    Gynecol Oncol. 2020;156:498-502.
    PubMed     Abstract available


    January 2020
  26. BERTOLI HK, Thomsen LT, Iftner T, Dehlendorff C, et al
    Risk of vulvar, vaginal and anal high-grade intraepithelial neoplasia and cancer according to cervical human papillomavirus (HPV) status: A population-based prospective cohort study.
    Gynecol Oncol. 2020 Jan 30. pii: S0090-8258(20)30082.
    PubMed     Abstract available


  27. TRIMBLE CL, Levinson K, Maldonado L, Donovan MJ, et al
    A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2/3 (CIN2/3).
    Gynecol Oncol. 2020 Jan 28. pii: S0090-8258(19)31865.
    PubMed     Abstract available


  28. LI T, Wu Z, Jiang M, Zhao Y, et al
    Clinical performance of Onclarity HPV assay and Cobas HPV test in detection of cervical precancer and cancer in Chinese women.
    Gynecol Oncol. 2020 Jan 18. pii: S0090-8258(20)30022.
    PubMed     Abstract available


    December 2019
  29. CLARK KT, Trimble CL
    Current status of therapeutic HPV vaccines.
    Gynecol Oncol. 2019 Dec 20. pii: S0090-8258(19)31838.
    PubMed     Abstract available


    November 2019
  30. HIROSE S, Murakami N, Takahashi K, Kuno I, et al
    Genomic alterations in STK11 can predict clinical outcomes in cervical cancer patients.
    Gynecol Oncol. 2019 Nov 19. pii: S0090-8258(19)31606.
    PubMed     Abstract available


  31. MALAGON T, Louvanto K, Ramanakumar AV, Koushik A, et al
    Viral load of human papillomavirus types 16/18/31/33/45 as a predictor of cervical intraepithelial neoplasia and cancer by age.
    Gynecol Oncol. 2019;155:245-253.
    PubMed     Abstract available


    October 2019
  32. WU P, Xiong H, Yang M, Li L, et al
    Co-infections of HPV16/18 with other high-risk HPV types and the risk of cervical carcinogenesis: A large population-based study.
    Gynecol Oncol. 2019 Oct 8. pii: S0090-8258(19)31560.
    PubMed     Abstract available


  33. GULERIA C, Suri V, Kapoor R, Minz RW, et al
    Human papillomavirus 16 infection alters the Toll-like receptors and downstream signaling cascade: A plausible early event in cervical squamous cell carcinoma development.
    Gynecol Oncol. 2019;155:151-160.
    PubMed     Abstract available


    August 2019
  34. HIRAO N, Iwata T, Tanaka K, Nishio H, et al
    Transcription factor homeobox D9 is involved in the malignant phenotype of cervical cancer through direct binding to the human papillomavirus oncogene promoter.
    Gynecol Oncol. 2019 Aug 30. pii: S0090-8258(19)31478.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Sexually Transmitted Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: